Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats - Wikidata - awgldk - TriplyDB

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

http://www.wikidata.org/entity/Q28577463

about

ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura Causes of thrombocytopenia in chronic hepatitis C viral infection.Defective ADAMTS13 synthesis as a possible consequence of NASH in an obese patient with recurrent thrombotic thrombocytopenic purpura.Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C.Structure-function and regulation of ADAMTS-13 protease.Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis.ADAMTS13: more than a regulator of thrombosis.Negundoside, an irridiod glycoside from leaves of Vitex negundo, protects human liver cells against calcium-mediated toxicity induced by carbon tetrachloride.Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease.Thrombotic thrombocytopenic purpura ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis

P2860

Q28083264-CEEC046D-7A22-430B-A1C2-F3E0313C00B2 Q33399654-7166FAC0-EE42-49F7-8F17-F5784E9E5031 Q33412873-FA26BFE3-09B3-48FA-BE9B-F8CB7DA1F049 Q35946802-40429005-5A6F-40F2-9AA7-C245118B8A77 Q37019574-D09F0C2F-D209-49A1-A4E0-CCE6C3A0E6D6 Q38368635-09F68E45-CBC3-4978-B721-A83A527EA0D8 Q38970545-883EDBE3-7194-43BE-B0FE-764862A53ABA Q39966158-B86ADD6B-9BD0-42E0-9A8C-D5E0E2E0BAD4 Q42838956-54CD58B4-B122-43B7-89DC-14A570DEDF53 Q57379903-DEB696C5-0725-4CBE-A365-9D3DFFB2D6EC Q58481440-DFC00B1E-38B2-4221-9143-43AE87749156

P2860

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

http://www.wikidata.org/entity/Q28577463

description

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2007

@ast

im April 2007 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2007/04/17)

@sk

vědecký článek publikovaný v roce 2007

@cs

wetenschappelijk artikel (gepubliceerd op 2007/04/17)

@nl

наукова стаття, опублікована у квітні 2007

@uk

مقالة علمية (نشرت في 17-4-2007)

@ar

name

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@ast

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@en

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@nl

type

label

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@ast

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@en

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@nl

prefLabel

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@ast

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@en

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@nl

P1433

Q28577463-D1C97D54-685B-41EE-A41B-AC52F9073827

P1476

Q28577463-C11A9744-5701-45A4-AE07-E39210F41BDB

P2093

Q28577463-3B5B01BF-300D-40F8-B2F9-D515FA171FA9

Q28577463-3B8DFEF9-755B-4AF2-91EC-CA5A31BF271C

Q28577463-3EE5F194-1358-4B11-AB4A-C8759684F889

Q28577463-467DCDD4-3CA0-4F7D-98A9-0ACD312EF2AC

Q28577463-4D787569-FA46-47EF-9AFB-B098F23D2A3F

Q28577463-55508B6E-7B3D-4C00-8FC3-865D6D59387A

Q28577463-5721B78C-9E90-4928-824A-68E89551F9D4

Q28577463-67DD9910-F8F7-4314-9D0D-2D54E813D1C4

Q28577463-7F507AC8-A0BB-41FB-88EA-4EC31E23F9B4

Q28577463-A2435090-0896-4FFF-AE7C-23D5625C6B33

P2860

Q28577463-11B2D9D5-9C42-49EF-A398-8C7DC0FEC364

Q28577463-1C6FDDF1-CDFC-45FA-B1FE-E2E9CB671E6B

Q28577463-37CE5754-B0C3-411B-A92B-44268587F47B

Q28577463-458D92EC-025D-4DB9-BA42-77E3DACF9E93

Q28577463-4BAE6BF7-E047-495A-AC7E-8F6B73438FC8

Q28577463-6B0CF770-FD84-4504-B670-294FF05BE1E6

Q28577463-6EF1CE37-14A8-42A1-B5CF-D37B862F2EEB

Q28577463-8E78EFA9-1C0E-4E91-8DCA-75B7FD38404A

Q28577463-9640DDFB-29D7-41A0-90A6-FF87F3CE02AF

Q28577463-9DFAB58F-EF44-4DB1-9440-A075F2331270

P304

Q28577463-88E88F9E-A267-4540-9B4D-AD45F586FADB

P31

Q28577463-74BE049C-E7DA-407F-8EEA-ADDE95B1F506

P356

Q28577463-8B3CEC9C-B31F-435B-8D1C-0D917030FFBA

P407

Q28577463-B0C25A73-585A-4EF2-B571-5A3259B136C2

P433

Q28577463-ACE19AA7-A63C-4149-A8AA-3E067C97ADE8

P478

Q28577463-141B41C6-A861-45BD-9062-5097965BCBE4

P577

Q28577463-6C150C15-668E-4E18-B86B-E2B05B8D28A7

P5875

Q28577463-B4B8C5B3-EF8B-4BAC-8227-595A164362EB

P698

Q28577463-56785105-F80E-4D5B-A213-DFEE49920ACE

P356

J.FEBSLET.2007.03.029

P1433

P1476

Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats

@en

P2093

Hiromitsu Yokota

http://www.w3.org/2001/XMLSchema#string

Hitoshi Ikeda

http://www.w3.org/2001/XMLSchema#string

Kazuaki Tejima

http://www.w3.org/2001/XMLSchema#string

Kenji Fujiwara

http://www.w3.org/2001/XMLSchema#string

Makoto Kaneko

http://www.w3.org/2001/XMLSchema#string

Masao Omata

http://www.w3.org/2001/XMLSchema#string

Morihiro Inoue

http://www.w3.org/2001/XMLSchema#string

Naoko Watanabe

http://www.w3.org/2001/XMLSchema#string

Shigeo Okubo

http://www.w3.org/2001/XMLSchema#string

Takako Nishikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura

Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo

Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura.

Deficient activity of von Willebrand factor-cleaving protease in patients with Upshaw-Schulman syndrome.

Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.

Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura.

Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases.

Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity.

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains.

P304

1631–1634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FEBSLET.2007.03.029

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

581

http://www.w3.org/2001/XMLSchema#string

P577

2007-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6423183

http://www.w3.org/2001/XMLSchema#string

P698

17383642

http://www.w3.org/2001/XMLSchema#string